相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
Orhan Aktas et al.
ANNALS OF NEUROLOGY (2021)
Current multidisciplinary management of brain metastases
Michael J. Moravan et al.
CANCER (2020)
Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy
Su-Hyun Kim et al.
SCIENTIFIC REPORTS (2020)
Neurofilament Light Chain as A Biomarker for Brain Metastases
Anne Winther-Larsen et al.
CANCERS (2020)
S100B as a biomarker for brain metastases in patients with non-small cell lung cancer
Maria Kondrup et al.
BIOMEDICAL REPORTS (2020)
Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
Kristin N. Varhaug et al.
FRONTIERS IN NEUROLOGY (2019)
Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis
Yinan Zhao et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
NfL (Neurofilament Light Chain) Levels as a Predictive Marker for Long-Term Outcome After Ischemic Stroke
Timo Uphaus et al.
STROKE (2019)
Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment
Patrick Oeckl et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Over-expression of S100B protein as a serum marker of brain metastasis in non-small cell lung cancer and its prognostic value
Lijuan Chen et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas
Adriana Hepner et al.
WORLD JOURNAL OF ONCOLOGY (2019)
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey
Antonin Levy et al.
EUROPEAN JOURNAL OF CANCER (2018)
Neurofilaments as biomarkers in neurological disorders
Michael Khalil et al.
NATURE REVIEWS NEUROLOGY (2018)
Brain metastases as first manifestation of advanced cancer: exploratory analysis of 459 patients at a tertiary care center
L. M. Fuereder et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
The expression of S100B protein in serum of patients with brain metastases from small-cell lung cancer and its clinical significance
Shanling Mu et al.
ONCOLOGY LETTERS (2017)
S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer
Humberto Choi et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Response assessment criteria for brain metastases: proposal from the RANO group
Nancy U. Lin et al.
LANCET ONCOLOGY (2015)
Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline
M. J. Gil-Gil et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2014)
Predicting brain metastases of breast cancer based on serum S100B and serum HER2
Troels Bechmann et al.
ONCOLOGY LETTERS (2013)
S100B protein as a possible participant in the brain metastasis of NSCLC
Xiaowen Pang et al.
MEDICAL ONCOLOGY (2012)
Epidemiology of Brain Metastases
Lakshmi Nayak et al.
CURRENT ONCOLOGY REPORTS (2012)
Astroglial Proteins as Diagnostic Markers of Acute Intracerebral Hemorrhage-Pathophysiological Background and Clinical Findings
Robert Brunkhorst et al.
TRANSLATIONAL STROKE RESEARCH (2010)
Molecular dissection of reactive astrogliosis and glial scar formation
Michael V. Sofroniew
TRENDS IN NEUROSCIENCES (2009)
Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization
Daniel P. Fitzgerald et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
Differential reactions of microglia to brain metastasis of lung cancer
Bei Ping He et al.
MOLECULAR MEDICINE (2006)
High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation
HJ Mamon et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Treatment of brain metastases from lung cancer: chemotherapy
W Schuette
LUNG CANCER (2004)
Confidence intervals for the effect of a prognostic factor after selection of an 'optimal' cutpoint
N Holländer et al.
STATISTICS IN MEDICINE (2004)
分享论文
